Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dermatophytes are a specialized group of filamentous fungi that require keratin for growth and survival, primarily belonging to the genera Trichophyton, Microsporum, and Epidermophyton [StatPearls, 2023]. These organisms colonize keratinized tissues such as the stratum corneum of the skin, hair shafts, and nails, leading to infections collectively known as dermatophytoses or tinea [NIH, 2022]. They possess unique enzymes, such as keratinases, which allow them to break down and utilize keratin as a nutrient source [PubMed, 2021]. While not a single molecular target, they are the biological focus of various antifungal therapies that disrupt essential fungal processes like ergosterol biosynthesis or microtubule formation [Wikipedia, 2024]. Treatment often involves topical or systemic agents depending on the severity and location of the infection [CDC, 2023]. These fungi are classified based on their primary habitat as anthropophilic, zoophilic, or geophilic, which influences the clinical presentation and inflammatory response in the host [StatPearls, 2023].
Antifungal drugs targeting dermatophytes primarily act by inhibiting ergosterol biosynthesis, a critical component of the fungal cell membrane. Allylamines like terbinafine inhibit squalene epoxidase, while azoles like itraconazole inhibit lanosterol 14-alpha-demethylase [StatPearls, 2023]. Additionally, griseofulvin disrupts fungal mitosis by binding to tubulin and interfering with microtubule assembly [PubMed, 2020].
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dermatophyte.